Should I Buy ARWR Stock in 2026?
Data-driven analysis and honest assessment for Arrowhead Pharmaceuticals Inc
Current Price: $70.53P/E: 43.8
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
High P/E of 43.8 indicates premium
Exceptional growth of 52%
Thin margins (0% net)
Financial health data limited
Low FCF yield of 2.3%
No recent insider activity
Key Investment Metrics
Current Price
$70.53
P/E Ratio
43.83
Revenue Growth
104.6%
Profit Margin
0.2%
Market Cap
$9.8B
Dividend Yield
None
How ARWR Compares to Competitors
Understanding how ARWR stacks up against peers helps inform your investment decision.
How ARWR Compares to Peers
Upcoming Events for ARWR
+5 Reasons TO Buy ARWR
1. Revenue growing 105% year-over-year
strongStrong top-line growth indicates robust demand and expanding market opportunity.
2. High gross margins of 100%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy ARWR
1. Thin profit margins of 0.2%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Expensive valuation at 44x earnings
medium riskP/E of 44 is significantly above averages. High expectations leave little room for disappointment.
Who Should Buy ARWR?
Investment Profile
Risk Level
High
Recommended Holding Period
5+ years (growth story needs time)
Best For:
- ✓
Growth Investors
105% revenue growth aligns with growth strategies
- ✓
Momentum Traders
High-growth profile attracts momentum
Not Suitable For:
- ✗
Value Investors
Premium P/E of 44 doesn't fit value criteria
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in ARWR, compare these Health Care peers:
Pro tip: Compare ARWR directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ARWR
Frequently Asked Questions
What is ARWR stock price today?
ARWR (Arrowhead Pharmaceuticals Inc) stock is trading at $70.53 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is ARWR stock going up or down today?
ARWR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ARWR stock now?
The decision to buy ARWR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ARWR a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ARWR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ARWR stock overvalued or undervalued?
ARWR currently trades at a P/E ratio of 43.83, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if ARWR is fairly priced.
What is ARWR's P/E ratio?
ARWR has a price-to-earnings (P/E) ratio of 43.83, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is ARWR's market cap?
ARWR (Arrowhead Pharmaceuticals Inc) has a market capitalization of $9.82 billion, making it a small-cap stock.
What is ARWR's price to book ratio?
ARWR trades at a price-to-book (P/B) ratio of 18.13, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Arrowhead Pharmaceuticals Inc
Full Stock Analysis
Complete ARWR overview with charts and data
Is ARWR Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how ARWR stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Arrowhead Pharmaceuticals Inc
Complete ARWR Analysis
Compare ARWR With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.